JP2006508178A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006508178A5 JP2006508178A5 JP2004571158A JP2004571158A JP2006508178A5 JP 2006508178 A5 JP2006508178 A5 JP 2006508178A5 JP 2004571158 A JP2004571158 A JP 2004571158A JP 2004571158 A JP2004571158 A JP 2004571158A JP 2006508178 A5 JP2006508178 A5 JP 2006508178A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- group
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 72
- 239000000203 mixture Substances 0.000 claims 60
- 125000003118 aryl group Chemical group 0.000 claims 39
- 125000003545 alkoxy group Chemical group 0.000 claims 27
- 229910052739 hydrogen Inorganic materials 0.000 claims 27
- 150000001875 compounds Chemical class 0.000 claims 26
- 125000001475 halogen functional group Chemical group 0.000 claims 24
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 24
- 125000003342 alkenyl group Chemical group 0.000 claims 21
- 125000000304 alkynyl group Chemical group 0.000 claims 21
- 125000004429 atom Chemical group 0.000 claims 21
- 125000000623 heterocyclic group Chemical group 0.000 claims 21
- 241000894006 Bacteria Species 0.000 claims 18
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 18
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 18
- 125000002252 acyl group Chemical group 0.000 claims 18
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 18
- 125000004452 carbocyclyl group Chemical group 0.000 claims 18
- 125000004093 cyano group Chemical group *C#N 0.000 claims 18
- 125000004122 cyclic group Chemical group 0.000 claims 18
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims 18
- -1 nitro, hydroxyl Chemical group 0.000 claims 18
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims 15
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims 15
- 125000005884 carbocyclylalkyl group Chemical group 0.000 claims 15
- 229910052799 carbon Inorganic materials 0.000 claims 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 12
- 125000003282 alkyl amino group Chemical group 0.000 claims 12
- 125000004414 alkyl thio group Chemical group 0.000 claims 12
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 12
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 9
- 125000002877 alkyl aryl group Chemical group 0.000 claims 9
- 125000003710 aryl alkyl group Chemical group 0.000 claims 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims 9
- 125000001072 heteroaryl group Chemical group 0.000 claims 9
- 125000006652 (C3-C12) cycloalkyl group Chemical group 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 241000588653 Neisseria Species 0.000 claims 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 6
- 125000002837 carbocyclic group Chemical group 0.000 claims 6
- 150000001721 carbon Chemical class 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 125000006413 ring segment Chemical group 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000011593 sulfur Substances 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 102000007528 DNA Polymerase III Human genes 0.000 claims 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 4
- 108010071146 DNA Polymerase III Proteins 0.000 claims 4
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- 241000193830 Bacillus <bacterium> Species 0.000 claims 3
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 241000193403 Clostridium Species 0.000 claims 3
- 241000194033 Enterococcus Species 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 claims 3
- 108090000790 Enzymes Proteins 0.000 claims 3
- 241000588722 Escherichia Species 0.000 claims 3
- 241000589989 Helicobacter Species 0.000 claims 3
- 241000589248 Legionella Species 0.000 claims 3
- 208000007764 Legionnaires' Disease Diseases 0.000 claims 3
- 241000186781 Listeria Species 0.000 claims 3
- 241000204031 Mycoplasma Species 0.000 claims 3
- 241000589516 Pseudomonas Species 0.000 claims 3
- 241000607142 Salmonella Species 0.000 claims 3
- 241000607768 Shigella Species 0.000 claims 3
- 241000191940 Staphylococcus Species 0.000 claims 3
- 241000194017 Streptococcus Species 0.000 claims 3
- 241000607734 Yersinia <bacteria> Species 0.000 claims 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 3
- 125000005128 aryl amino alkyl group Chemical group 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 125000002950 monocyclic group Chemical group 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 108020000946 Bacterial DNA Proteins 0.000 claims 1
- 241000192125 Firmicutes Species 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 230000000840 anti-viral effect Effects 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 238000007917 intracranial administration Methods 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 229910021654 trace metal Inorganic materials 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 0 *C(*)=NN(*)C(C1=N*C(c2cc(*)c(*)c(*)c2)=C1)=O Chemical compound *C(*)=NN(*)C(C1=N*C(c2cc(*)c(*)c(*)c2)=C1)=O 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40943902P | 2002-09-10 | 2002-09-10 | |
| PCT/US2003/028392 WO2004094370A2 (en) | 2002-09-10 | 2003-09-10 | Antibacterial pyrazole carboxylic acid hydrazides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006508178A JP2006508178A (ja) | 2006-03-09 |
| JP2006508178A5 true JP2006508178A5 (cg-RX-API-DMAC10.html) | 2007-09-13 |
Family
ID=33309471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004571158A Withdrawn JP2006508178A (ja) | 2002-09-10 | 2003-09-10 | 抗菌性ピラゾールカルボン酸ヒドラジド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060258729A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1549143A2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2006508178A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2003303953B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2497410A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2004094370A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006017505A2 (en) * | 2004-08-04 | 2006-02-16 | Schering Corporation | Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases |
| US7786139B2 (en) | 2006-11-21 | 2010-08-31 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| WO2011031935A1 (en) * | 2009-09-11 | 2011-03-17 | Glsynthesis Inc. | Selective antibacterials for clostridium difficile infections |
| WO2014059429A2 (en) * | 2012-10-12 | 2014-04-17 | Health Research, Inc. | Small molecules inhibiting oncoprotein myc |
| US20240139191A1 (en) * | 2020-12-14 | 2024-05-02 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Small molecules as larp1 ligands |
| UY39882A (es) * | 2021-08-02 | 2023-06-15 | Eurofarma Laboratorios S A | COMPUESTOS NACILHIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7232685B2 (en) * | 2001-12-19 | 2007-06-19 | The Regents Of The Universtiy Of California | Cell lines with latent immunodeficiency virus and methods of use thereof |
| WO2003105840A2 (en) * | 2002-06-17 | 2003-12-24 | The Pennsylvania State Research Foundation | Sphingosine kinase inhibitors |
-
2003
- 2003-09-10 AU AU2003303953A patent/AU2003303953B2/en not_active Expired - Fee Related
- 2003-09-10 WO PCT/US2003/028392 patent/WO2004094370A2/en not_active Ceased
- 2003-09-10 EP EP03816116A patent/EP1549143A2/en not_active Withdrawn
- 2003-09-10 CA CA002497410A patent/CA2497410A1/en not_active Abandoned
- 2003-09-10 US US10/527,037 patent/US20060258729A1/en not_active Abandoned
- 2003-09-10 JP JP2004571158A patent/JP2006508178A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1432705B1 (en) | Dual action antibiotics | |
| JP2004502752A5 (cg-RX-API-DMAC10.html) | ||
| RU2410386C2 (ru) | Новые соединения, обладающие антибактериальной активностью | |
| WO2004062601A3 (en) | Antibacterial agents | |
| DE60039238D1 (de) | C-2-modifizierte erythromycinderivate | |
| WO2004096823A3 (en) | Novel ketolide derivatives | |
| AP2003002942A0 (en) | New derivatives of oxazolidinones as bacterial agents | |
| WO2004087728A3 (en) | 6,11-3c-bicyclic 9a-azalide derivatives | |
| US20040132764A1 (en) | Antibiotics for the treatment of infections in acidic environments | |
| IL87144A (en) | Pharmaceutical preparations containing naphthyridine carboxylic acids and process | |
| JP2001072684A5 (cg-RX-API-DMAC10.html) | ||
| US7812008B2 (en) | 9-substituted tetracyclines | |
| WO2003066064A2 (en) | Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics | |
| EP1101769A3 (en) | Nitrogen containing erythromycin derivatives | |
| WO2006063039A3 (en) | 3, 6-bicyclolides | |
| JP2000026494A5 (cg-RX-API-DMAC10.html) | ||
| JP2005504734A5 (cg-RX-API-DMAC10.html) | ||
| CA2451768A1 (en) | Peptoid compounds | |
| HRP20120634T1 (hr) | Antibiotik 107891, njegovi faktori, farmaceutski prihvatljive soli i sastavi, te njihova uporaba | |
| Sakurai et al. | Synthesis and structure-activity relationships of 7-(2-aminoalkyl) morpholinoquinolones as anti-Helicobacter pylori agents | |
| Foroumadi et al. | Synthesis and in‐vitro antibacterial activity of new N‐substituted piperazinyl quinolones | |
| NO20015346D0 (no) | Haloderivater av 9-deoksy-9A-aza-9A-homoerytromycin A | |
| JP2002507616A5 (cg-RX-API-DMAC10.html) | ||
| US20040044006A1 (en) | Methods of use of quinolone compounds against pneumococcal and haemophilus bacteria | |
| IL183153A0 (en) | 8a, 9-DIHYDRO-4a-H-ISOTHIAZOLO[5,4-b]QUINOLINE-3,4-DIONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS |